Kimberly-Clark (NASDAQ:KMB – Get Free Report) had its price target reduced by equities research analysts at Wells Fargo & Company from $129.00 to $110.00 in a report issued on Tuesday,Benzinga reports. The firm currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective suggests a potential upside of 9.73% from the stock’s current price.
KMB has been the topic of several other research reports. Weiss Ratings initiated coverage on shares of Kimberly-Clark in a research report on Thursday, October 30th. They set a “hold (c+)” rating on the stock. Royal Bank Of Canada restated an “overweight” rating and set a $162.00 price objective on shares of Kimberly-Clark in a research report on Tuesday, October 28th. TD Cowen reduced their target price on shares of Kimberly-Clark from $135.00 to $130.00 and set a “hold” rating for the company in a research report on Friday. Citigroup lowered their target price on shares of Kimberly-Clark from $118.00 to $113.00 and set a “sell” rating for the company in a research note on Thursday, October 9th. Finally, UBS Group increased their price target on shares of Kimberly-Clark from $130.00 to $132.00 and gave the stock a “neutral” rating in a research report on Friday. Two investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Kimberly-Clark has an average rating of “Hold” and an average price target of $130.33.
Get Our Latest Stock Report on Kimberly-Clark
Kimberly-Clark Stock Down 2.0%
Kimberly-Clark (NASDAQ:KMB – Get Free Report) last issued its earnings results on Thursday, October 30th. The company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.45 by $0.37. Kimberly-Clark had a net margin of 12.87% and a return on equity of 184.87%. The firm had revenue of $4.15 billion for the quarter, compared to the consensus estimate of $4.14 billion. During the same quarter in the prior year, the firm posted $1.83 earnings per share. The business’s revenue was up .1% on a year-over-year basis. Equities research analysts forecast that Kimberly-Clark will post 7.5 EPS for the current year.
Hedge Funds Weigh In On Kimberly-Clark
Institutional investors and hedge funds have recently bought and sold shares of the stock. Brighton Jones LLC raised its position in shares of Kimberly-Clark by 74.1% in the 4th quarter. Brighton Jones LLC now owns 6,494 shares of the company’s stock valued at $851,000 after purchasing an additional 2,765 shares in the last quarter. Penserra Capital Management LLC raised its position in shares of Kimberly-Clark by 629.0% in the 1st quarter. Penserra Capital Management LLC now owns 6,379 shares of the company’s stock valued at $906,000 after purchasing an additional 5,504 shares in the last quarter. Capital Advisors Inc. OK raised its position in shares of Kimberly-Clark by 19.6% in the 1st quarter. Capital Advisors Inc. OK now owns 2,019 shares of the company’s stock valued at $287,000 after purchasing an additional 331 shares in the last quarter. Beverly Hills Private Wealth LLC raised its position in shares of Kimberly-Clark by 5.9% in the 1st quarter. Beverly Hills Private Wealth LLC now owns 3,030 shares of the company’s stock valued at $431,000 after purchasing an additional 170 shares in the last quarter. Finally, Valeo Financial Advisors LLC raised its position in shares of Kimberly-Clark by 3.3% in the 1st quarter. Valeo Financial Advisors LLC now owns 13,234 shares of the company’s stock valued at $1,882,000 after purchasing an additional 425 shares in the last quarter. Hedge funds and other institutional investors own 76.29% of the company’s stock.
Kimberly-Clark Company Profile
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Recommended Stories
- Five stocks we like better than Kimberly-Clark
- NYSE Stocks Give Investors a Variety of Quality Options
- Intel’s SambaNova Play Isn’t an Acquisition, It’s an Ambush
- Airline Stocks – Top Airline Stocks to Buy Now
- Why Roblox Stock Could Soar 75% After the Q3 Dip
- Compound Interest and Why It Matters When Investing
- Amazon vs. Apple: Which Mag 7 Is the Better Buy?
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.
